HAS3 and neuroblastoma: Differentiation therapy is one way to control the growth of neuroblastoma cells by initiating differentiation and apoptosis.36 In this study, we demonstrated that serum starvation, as well as exposure to physiological levels (<10 nmol/L) of melatonin, induced N2a cell differentiation via the activation of HAS3‐mediated signals.